Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Summary:
Main Objective: to evaluate the efficacy of pelvic gonadal vein embolization with coils in treatment of pelvic congestion syndrome Methods: retrospective study included 25 patients in the University hospital of Brest.
The Primary Outcome Measure: To evaluate (to measure) pain relief using visual analogous scale (VAS) before and after gonadal vein embolization for pelvic congestion syndrome The Secondary Outcome Measures were to assess the impact of the treatment on specific and general symptoms through a survey.
A retrospective, non-invasive monocentric study of our Hospital 10-year registry (including data on MRI angiography and Vascular Doppler Ultrasound) of patients who have already undergone coil embolization of pelvic gonadal vein in treatment of pelvic congestion syndrome. These patients will be contacted by phone to participate in the study. An information letter will be handed out and the study protocol will be explained to the patients. After obtaining their written consent, they will be asked to fill out the study's validated questionnaire at home and return it to us through pre-paid regular mail. A face to face interview with the patient will be scheduled to assess the correlation between patient's clinical symptoms and survey results. There will be no change in patient's routine follow-up care.
All physician investigators of the study are experts in their field of medicine (e.g. interventional MRI angiography, vascular disease).
Not provided
Not provided
Not provided
Not provided
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Pelvic congestion pain relief | To evaluate (to measure) pain relief using visual analogous scale before and after gonadal vein embolization for pelvic congestion syndrome. A high score means a worse outcome. | pre-embolization and 1 month post-gonadal vein embolization |
| Measure | Description | Time Frame |
|---|---|---|
| evaluation of specific pelvic syndrome symptoms using a self-reported questionnaire survey | to assess the impact of gonadal vein embolization on specific symptoms of pelvic congestion syndrome through a self-reported questionnaire survey. | pre-embolization and 1 month post-gonadal vein embolization |
| evaluation of general pelvic syndrome symptoms using a self-reported questionnaire survey |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
women > 18 years old with at least 1 previous pregnancy and delivery
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Philippe QUEHE | Contact | 02 98 34 75 45 | philippe.quehe@chu-brest.fr |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| CHRU de Brest | Recruiting | Brest | 29609 | France |
Not provided
Data will be available beginning one year and ending five years following the end of the study
Data access requests will be reviewed by the internal committee of Brest University Hospital. Requestors will be required to sign and complete a data access agreement.
Not provided
Not provided
| ID | Term |
|---|---|
| D017699 | Pelvic Pain |
| D013577 | Syndrome |
| D010146 | Pain |
| ID | Term |
|---|---|
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
| D004194 | Disease |
Not provided
Not provided
Not provided
Not provided
Not provided
to assess the impact of gonadal vein embolization on general symptoms of pelvic congestion syndrome through a self-reported questionnaire survey. |
| pre-embolization and 1 month post-gonadal vein embolization |
| D010335 | Pathologic Processes |